Press Release

CSRxP STATEMENT ON PCMA LAWSUIT CHALLENGING TRUMP ADMINISTRATION’S REBATE RULE

Jan 12, 2021

Misguided Policy Published in Violation of Legally Required Process for Public Read More

HAPPY NEW YEAR: BIG PHARMA HIKES PRICES ON MORE THAN 580 RX DRUGS TO START 2021

Jan 4, 2021

Drug Companies Double Down In Second Major Round Of Pandemic Price Hikes As Read More

CSRXP STATEMENT ON SELECTION OF XAVIER BECERRA FOR THE U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES

Dec 7, 2020

Campaign Looks Forward to Working with Becerra to Lower Drug Prices Read More

CSRXP: BIG PHARMA MUST BE HELD ACCOUNTABLE FOR ESCALATING ASSAULT ON CRITICAL 340B PROGRAM

Dec 3, 2020

Novo Nordisk Becomes Latest Drug Company to Dodge Requirement to Provide Read More

CSRxP: MISGUIDED REBATE RULE A BIG PHARMA BAILOUT PAID FOR BY AMERICAN SENIORS & TAXPAYERS

Nov 20, 2020

Rebate Rule Will Increase Premiums for Medicare Part D Beneficiaries Read More

CSRXP: COVID-19 TREATMENTS AND VACCINES MUST BE ACCESSIBLE AND AFFORDABLE FOR ALL AMERICANS

Nov 9, 2020

Pfizer Releases Positive Preliminary Data on Vaccine, Must Commit to Read More

CSRXP: GILEAD’S PRICE-GOUGING AMERICAN PUBLIC ON COVID-19 TREATMENT TAXPAYERS PAID TO DEVELOP

Oct 30, 2020

Big Pharma Company Reaping Profit Margin Higher Than 90 Percent on Remdesivir Read More

CSRXP: PRESIDENTIAL CAMPAIGNS MUST BACK BIPARTISAN, MARKET-BASED SOLUTIONS TO HOLD BIG PHARMA ACCOUNTABLE

Oct 13, 2020

Surrogates for the 2020 Candidates Should Demonstrate Commitment To Lowering Read More

CSRXP: ASTRAZENECA LEADS BIG PHARMA IN BRAZEN ASSAULT ON CRITICAL 340B PROGRAM, MUST BE HELD ACCOUNTABLE

Oct 1, 2020

Brand Name Drug Company Shirks Requirement to Provide Affordable Medications Read More

NEW STUDY: BIG PHARMA’S BIOLOGIC PATENT ABUSE WILL COST AMERICAN PATIENTS AN ADDITIONAL $25 BILLION WITHOUT REFORM

Sep 22, 2020

Report Finds Market-Based Solutions to Boost Biosimilar Competition and Hold Read More

CSRXP: PRESIDENT SHOULD FOCUS ON HOLDING BIG PHARMA ACCOUNTABLE TO LOWER RX PRICES, ABANDON REBATE RULE

Sep 13, 2020

Tweet Misstates Impact of Misguided Rebate Rule That Would Do Nothing to Lower Read More

BIG PHARMA DOUBLES DOWN ON SUMMER PRICE HIKES AS AMERICANS CONTINUE TO BATTLE PANDEMIC

Aug 27, 2020

Tracking Data Finds Drug Companies Increased Prices On at Least 67 Brand Name Read More